Literature DB >> 11563853

Histone deacetylase and DNA methyltransferase in human prostate cancer.

S K Patra1, A Patra, R Dahiya.   

Abstract

CpG island hypermethylation and chromatin remodeling play important roles in repression of various genes during malignant transformation. We hypothesized that histone deacetylases (HDACs) and DNA methyltransferases (DNMTase) are associated with prostate cancer and we examined the enzyme activity, gene, and protein expression of HDAC1 and DNMT1 in cell lines and tissues. We found that DNMTase and HDACs activities were two- to threefold higher in cell lines compared to benign prostatic hyperplasia (BPH-1) cell line. Treatment of cells with 5-aza-2'-deoxycytidine decreased the activity of HDAC and DNMTase. The mRNA expression of these genes in BPH-1 cells and BPH tissues was lower than that in prostate cancer cells and tissues. HDAC1 and DNMT1 protein expression was higher in prostate cancer compared to BPH. This is the first report to demonstrate that DNMT1 and HDAC1 levels are up-regulated in prostate cancer compared to BPH, suggesting their roles in inactivation of various genes, by DNA-methylation-induced chromatin-remodeling, in prostate cancer. Copyright 2001 Academic Press.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11563853     DOI: 10.1006/bbrc.2001.5639

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  49 in total

1.  Plant flavone apigenin inhibits HDAC and remodels chromatin to induce growth arrest and apoptosis in human prostate cancer cells: in vitro and in vivo study.

Authors:  Mitali Pandey; Parminder Kaur; Sanjeev Shukla; Ata Abbas; Pingfu Fu; Sanjay Gupta
Journal:  Mol Carcinog       Date:  2011-10-17       Impact factor: 4.784

2.  Sulforaphane retards the growth of human PC-3 xenografts and inhibits HDAC activity in human subjects.

Authors:  Melinda C Myzak; Philip Tong; Wan-Mohaiza Dashwood; Roderick H Dashwood; Emily Ho
Journal:  Exp Biol Med (Maywood)       Date:  2007-02

3.  Synthesis and activity of tumor-homing peptide iRGD and histone deacetylase inhibitor valproic acid conjugate.

Authors:  Zheng-Hong Peng; Jindřich Kopeček
Journal:  Bioorg Med Chem Lett       Date:  2014-03-12       Impact factor: 2.823

4.  Epigenetic mechanisms underlying diet-sourced compounds in the prevention and treatment of gastrointestinal cancer.

Authors:  Rebecca W Knackstedt; Vondina R Moseley; Michael J Wargovich
Journal:  Anticancer Agents Med Chem       Date:  2012-12       Impact factor: 2.505

5.  NOD/SCID mouse model of canine T-cell lymphoma with humoral hypercalcaemia of malignancy: cytokine gene expression profiling and in vivo bioluminescent imaging.

Authors:  M V P Nadella; W C Kisseberth; K S Nadella; N K Thudi; D H Thamm; E A McNiel; A Yilmaz; K Boris-Lawrie; T J Rosol
Journal:  Vet Comp Oncol       Date:  2008-03       Impact factor: 2.613

6.  Role for histone deacetylase 1 in human tumor cell proliferation.

Authors:  Silvia Senese; Katrin Zaragoza; Simone Minardi; Ivan Muradore; Simona Ronzoni; Alfonso Passafaro; Loris Bernard; Giulio F Draetta; Myriam Alcalay; Christian Seiser; Susanna Chiocca
Journal:  Mol Cell Biol       Date:  2007-04-30       Impact factor: 4.272

7.  Regulators of gene expression as biomarkers for prostate cancer.

Authors:  Stacey S Willard; Shahriar Koochekpour
Journal:  Am J Cancer Res       Date:  2012-11-20       Impact factor: 6.166

8.  Increased expression of histone deacetylaces (HDACs) and inhibition of prostate cancer growth and invasion by HDAC inhibitor SAHA.

Authors:  Longgui Wang; Xuanyi Zou; Aaron D Berger; Christian Twiss; Yi Peng; Yirong Li; Jason Chiu; Hongfeng Guo; Jaya Satagopan; Andrew Wilton; William Gerald; Ross Basch; Zhengxin Wang; Iman Osman; Peng Lee
Journal:  Am J Transl Res       Date:  2009-01-01       Impact factor: 4.060

9.  Histone acetylation regulates prostate ductal morphogenesis through a bone morphogenetic protein-dependent mechanism.

Authors:  Kimberly P Keil; Helene M Altmann; Lisa L Abler; Laura L Hernandez; Chad M Vezina
Journal:  Dev Dyn       Date:  2015-09-02       Impact factor: 3.780

10.  Prognostic significance of the therapeutic targets histone deacetylase 1, 2, 6 and acetylated histone H4 in cutaneous T-cell lymphoma.

Authors:  L Marquard; L M Gjerdrum; Ib J Christensen; P B Jensen; M Sehested; E Ralfkiaer
Journal:  Histopathology       Date:  2008-09       Impact factor: 5.087

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.